NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Effect of Kinesiotaping on Tremor in People With Parkinson's Disease
Effect of Kinesiotaping on Tremor in People With Parkinson's Disease

NCT07555847

CompletedNA

Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Conditions: PARKINSON DISEASE (Disorder), Tremor, Tremor Associated With Tremor Dominant Parkinson's Disease

Interventions: Therapeutic Kinesiotaping, Sham Taping, Home Exercise Program

Countries: Turkey (Türkiye)

The goal of this clinical trial is to learn whether adding kinesiotaping to a strengthening and stretching home-exercise program can reduce hand tremor and improve hand function in people with Parkinson's disease. The study will also examine how true kinesiotaping compares with sham (placebo) taping and with exercise alone in improving tremor frequency, grip strength, fine motor skills, motor symptoms, daily living activities, and quality of life. Adults aged 18-80 with Parkinson's disease and hand tremor will be randomly assigned to one of three groups: Kinesiotaping + Exercise Group: Participants will receive therapeutic kinesiotaping applied to the forearm extensor muscles and wrist for 4 weeks (twice weekly), in addition to a home program of strengthening and stretching exercises. Sham Taping + Exercise Group: Participants will receive a placebo taping without tension that does not target specific muscles, along with the same exercise program. Exercise-Only Group: Participants will complete the same home-exercise program without any taping. Researchers will compare the three groups to see whether kinesiotaping provides additional benefits beyond exercise and whether it performs better than sham taping. Tremor frequency will be measured using an Apple Watch device, and hand strength, dexterity, motor symptoms, and quality of life will be assessed using validated clinical scales.

Eligibility overview

Sex: ALL

Age: 18 Years to 80 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Diagnosis of idiopathic Parkinson's disease
* Hoehn and Yahr stage 1-4
* Presence of hand tremor
* Mini-Mental State Examination (MMSE) score ≥ 23
* Stable medical treatment for at least 3 months prior to enrollment and no planned changes during the study period
* Age between 18 and 80 years
* Ability to understand and provide written informed consent

Exclusion Criteria:

* Diagnosis of essential tremor or tremor due to causes other than Parkinson's disease
* Advanced motor impairment (severe bradykinesia or dyskinesia)
* History of allergic reaction to kinesiotaping materials
* Presence of other neurological disorders causing tremor (e.g., ALS, multiple sclerosis, cerebellar disorders)
* Severe psychiatric disorders (e.g., major depression, psychosis, severe anxiety)
Locations (1)
  • Istanbul, Uskudar, Turkey (Türkiye)